| Literature DB >> 24039780 |
Heidi Albert1, Lydia Nakiyingi, Joseph Sempa, Olive Mbabazi, Sheena Mukkada, Barnabas Nyesiga, Mark D Perkins, Yukari C Manabe.
Abstract
BACKGROUND: Light emitting diode (LED) fluorescence microscopy (FM) is an affordable, technology targeted for use in resource-limited settings and recommended for widespread roll-out by the World Health Organization (WHO). We sought to compare the operational performance of three LED FM methods compared to light microscopy in a cohort of HIV-positive tuberculosis (TB) suspects at an urban clinic in a high TB burden country.Entities:
Mesh:
Year: 2013 PMID: 24039780 PMCID: PMC3765165 DOI: 10.1371/journal.pone.0072556
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Diagram of study flow.
NTM = non-tuberculous mycobacteria, Mtb = Mycobacterium tuberculosis.
Performance of three LED-based fluorescence microscopy devices in detection of tuberculosis in HIV-positive suspects in Kampala, Uganda, per specimen analysis.
| ZN | Routine FM | iLED | Fraen | Lumin | |
|
| 31.1% (51/164) 24.1–38.8 | 32.9% (54/164) 25.8–40.7 | 40.2% (66/164) 32.7–48.2 | 42.1% (69/164) 34.4–50.0 | 38.4% (63/164) 30.9–46.3 |
| 3+ | 9 | 9 | 11 | 12 | |
| 2+ | 13 | 20 | 18 | 20 | |
| 1+ | 17 | 25 | 24 | 19 | |
| Scanty | 12 | 11 | 16 | 12 | |
| No grading | 0 | 1 | 0 | 0 | |
|
| 99.3% (425/428) 98.0–99.9 | 99.1% (424/428) 97.6–99.7 | 93.2% (399/428) 90.4–95.4 | 91.6% (392/428) 88.5–94.0 | 91.6% (392/428) 88.5–94.0 |
|
| 94.4% (51/54) 84.6–98.8 | 93.1% (54/58) 83.3–98.1 | 69.5% (66/95) 59.2–78.5 | 65.7% (69/105) 55.8–74.7 | 63.6% (63/99) 53.4–73.1 |
|
| 79.0% (425/538) 75.3–82.4 | 79.4% (424/534) 75.7–82.8 | 80.3% (399/428) 76.3–84.0 | 80.5% (392/487) 76.7–83.9 | 79.5% (392/493) 75.7–83.0 |
For sensitivity calculations, the denominator is the number of specimens for which the culture was positive for MTB. For specificity, the denominator shows the number of culture negative specimens.
Performance of three LED-based fluorescence microscopy devices in detection of tuberculosis in HIV-positive suspects in Kampala, Uganda, per patient analysis.
| ZN | Routine FM | iLED | Fraen | Lumin | |
|
| 32.4% (35/108) 23.7–42.0 | 32.4% (35/108) 23.7–42.0 | 44.4% (48/108) 34.9–54.3 | 43.5% (47/108) 34.0–53.3 | 40.7% (44/108) 31.3–50.6 |
| 3+ | 5 | 4 | 5 | 7 | |
| 2+ | 7 | 15 | 13 | 16 | |
| 1+ | 13 | 17 | 18 | 11 | |
| Scanty | 10 | 11 | 11 | 10 | |
| No grading | 0 | 1 | 0 | 0 | |
|
| 98.7% (234/237) 96.3–99.7 | 99.1% (235/237) 97.0–99.9 | 89.5% (212/237) 84.8–93.0 | 87.0% (206/237) 82.0–90.9 | 88.1% (209/237) 83.3–92.0 |
|
| 92.1% (35/38) 78.6–98.3 | 94.6% (35/37) 81.8–99.3 | 65.8% (48/73) 53.7–76.5 | 60.2% (47/78) 48.5–71.1 | 61.1% (44/72) 48.9–72.3 |
|
| 76.2% (234/307) 71.0–80.9 | 76.3% (235/308) 71.2–80.9 | 78.0% (212/272) 72.5–82.7 | 77.1% (206/267) 71.6–82.0 | 76.6% (219/273) 71.0–81.5 |
For sensitivity calculations, the denominator is the number of patients for which the culture was positive for MTB. For specificity, the denominator shows the number of culture negative patients. None of the 3 LED FM methods was significantly different from each other. ZN, ZiehlNeelsen staining method; FM, fluorescence microscopy; PPV, positive predictive value; NPV, negative predictive value.
Per reader analysis of performance of ZN and LED-based fluorescence microscopy methods, per specimen analysis.
| Overall | Reader 1 | Reader 2 | Reader 3 | Reader 4 | Reader 5 | Reader 6 | |
| Direct ZN Sensitivity | 31.1% (51/164) 24.1–38.8 | 40% (4/10) 12.2–73.8 | 35.9% (23/64) 24.3–48.9 | 26.7% (24/90) 17.9–37.0 | - | - | - |
| Direct ZN Specificity | 99.3% (425/428) 98.0–99.9 | 95.4% (41/43) 84.2–99.4 | 100.0% (125/125) 97.1–100 | 99.6% (259/260) 97.9–100 | - | - | - |
| Direct ZN PPV | 94.4% (51/54) 84.6–98.8 | 66.7% (4/6) 22.3–95.7 | 100.0% (23/23) 85.2–100 | 96.0% (24/25) 79.6–99.9 | - | - | - |
| Direct ZN NPV | 79.0% (425/538) 75.3–82.4 | 87.2% (41/47) 74.3–95.2 | 75.3% (125/166) 68.0–81.7 | 78.6% (259/325) 74.9–83.9 | - | - | - |
| iLED Sensitivity | 40.2% (66/164) 32.7–48.2 | - | - | - | 45.3% (34/75) 33.8–57.2 | 40.9% (9/22) 20.7–63.6 | 34.3% (23/67) 23.2–46.9 |
| iLED Specificity | 93.2% (399/428) 90.4–95.4 | - | - | - | 85.3% (156/183) 79.2–90.0 | 98.2% (54/55) 90.3–100 | 99.5% (189/190) 97.1–100 |
| iLED PPV | 69.5% (66/95) 59.2–78.5 | - | - | - | 55.7% (34/61) 42.4–68.5 | 90.0% (9/10) 55.5–99.7 | 95.8% (23/24) 78.9–99.9 |
| iLED NPV | 80.3% (399/497) 76.3–84.03 | - | - | - | 79.2% (156/197) 72.8–84.6 | 80.6% (54/67) 69.1–89.2 | 81.1% (189/233) 75.4–85.9 |
| Fraen Sensitivity | 42.1% (69/164) 34.4 50.0 | - | - | - | 49.3% (37/75) 37.6–61.1 | 40.9% (9/22) 20.7–63.6 | 34.3% (23/67) 23.2–46.9 |
| Fraen Specificity | 91.6% (392/428) 88.5–94.0 | - | - | - | 82.5% (151/183) 76.2–87.7 | 98.2% (54/55) 90.2–100 | 98.4% (187/190) 95.5–99.7 |
| Fraen PPV | 65.7% (69/105) 55.8–74.7 | - | - | - | 53.6% (37/69) 41.2–65.7 | 90.0% (9/10) 55.5–99.7 | 88.5% (23/26) 69.8–97.6 |
| Fraen NPV | 80.5% (392/487) 76.7–83.9 | - | - | - | 79.9% (151/189) 73.5–85.4 | 80.6% (54/67) 69.1–89.2 | 77.2% (187/231) 75.3–85.8 |
| Lumin Sensitivity | 38.4% (63/164) 0.9–46.3 | - | - | - | 46.7% (35/75) 35.1–58.6 | 36.4% (8/22) 17.2–59.3 | 29.9% (20/67) 19.3–42.3 |
| Lumin Specificity | 91.6% (392/428) 88.5–94.0 | - | - | - | 82.5% (151/183) 76.2–87.7 | 98.2% (54/55) 90.2–100 | 98.4% (187/190) 95.5–99.7 |
| Lumin PPV | 63.6% (63/99) 53.4–73.1 | - | - | - | 52.2% (35/67) 39.7–64.6 | 88.9% (8/9) 51.8–99.7 | 87% (20/23) 66.4–97.2 |
| Lumin NPV | 79.5% (392/493) 75.7–83.0 | - | - | - | 79.1% (151/191) 72.6–84.6 | 79.4% (54/68) 67.9–88.3 | 79.9% (187/234) 74.2–84.9 |
Readers 1–3 read ZN slides, readers 4–6 read LED FM slides (all LED systems for a single specimen were read by the same reader).
False positive results.
| iLED | Fraen | Lumin | |
| 3+ | 0 | 0 | |
| 2+ | 1 | 1 | 3 |
| 1+ | 11 | 11 | 12 |
| Scanty | 17 | 22 | 18 |
| No grading | 2 | 3 | |
|
|
|
|
|
| 21 Fraen(+), 23Lumin (+) | 21iLED (+), 24Lumin(+) | 24 Fraen(+), 23 iLED(+) |
Sensitivities compared to positive culture (LJ or MGIT) at different CD4 T cell strata.
| FM mic oscope | Reader 4: iLED | Reader 4: Fraen | Reader 4: Lumin | Reader 5: iLED | Reader 5: Fraen | Reader 5: Lumin | Reader 6: iLED | Reader 6: Fraen | Reader 6: Lumin | Overall: iLED | Overall: Fraen | Overall: Lumin | Overall-4: iLED | Overall-4: Fraen | Overall-4: Lumin |
| CD4<100 | 23.0% (3/13) (5.0–53.8) | 30.8% (4/13) (9.0–61.4) | 30.8% (4/13) (9.1–61.4) | 20.0% (1/5) (0.5–71.6) | 20.0% (1/5) (0.5–71.6) | 20.0% (1/5) (0.5–71.6) | 30.0% (3/10) (6.7–65.2) | 60.0% (6/10) (26.2–87.8) | 30.0% (3/10) (6.7–65.2) | 25.0% (7/28) (10.7–44.9) | 39.2% (11/28) (21.5–59.4) | 28.6% (8/28) (13.2–48.7) | 26.7% (4/15) (7.8–55.1) | 46.7% (7/15) (21.2–73.4) | 26.7% (4/15) (7.8–55.1) |
| CD4 101–250 | 33.3% (4/12) (10–65) | 41.7% (5/12) (15.2–72.3) | 33.3% (4/12) (10–65) | - | - | - | 24.0% (6/25) (9.4–45.1) | 28.0% (7/25) (12.1–49.4) | 20.0% (5/25) (6.8–40.7) | 24.4% (10/41) (12.4–40.3) | 29.3% (12/41) (16.1–45.5) | 21.9% (9/41) (10.6–37.6) | 20.7% (6/29) (8.0–39.7) | 24.1% (7/29) (10.3–43.5) | 17.2 % (5/29) (5.8–35.8) |
| CD4>250 | 53.1% (25/47) (38.0–67.9) | 55.3% (26/47) (40.1–69.8) | 53.1% (25/47) (38.1–67.9) | 66.7% (8/12) (34.9–90.0) | 66.7% (8/12) (34.9–90.0) | 58.3% (7/12) (27.7–84.8) | 41.7% (10/24) (22.1–63.3) | 33.3% (8/24) (15.6–55.3) | 33.3% (8/24) (15.6–55.3) | 51.8% (43/83) (40.6–62.9) | 50.6% (42/83) (39.3–61.8) | 48.1% (40/83) (37.1–59.4) | 50.0% (18/36) (32.9–67.0) | 44.4% (16/36) (27.9–61.9) | 41.7% (15/36) (25.5–59.2) |
| Overall | 44.4% (32/72) (32.7–56.6) | 48.6% (35/72) (36.7–60.7) | 45.8% (33/72) (34.0–58.0) | 42.9% (9/21) (21.8–66.0) | 42.9% (9/21) (21.8–66.0) | 38.1 % (8/21) (18.1–61.6) | 32.2% (19/59) (20.6–45.6) | 35.6% (21/59) (23.6–49.1) | 27.1 % (16/59) (16.3–40.2) | 39.5% (60/152) (31.6–47.7) | 42.8% (65/152) (34.8–51.0) | 37.5% (57/152) (29.8–45.7) | 35.0% (28/80) (24.7–46.4) | 37.5% (30/80) (26.9–49.0) | 30.0% (24/80) (20.2–41.2) |
Empty cells under reader 5 show that there were 13 patients and all tested negative for all 3 tests (i.e. iLed, Lumin, and Fraen). Overall-4 represents the overall sensitivities of readers 5 & 6 excluding reader 4 who had the highest false positivity rate. Table includes only those patients with a CD4 count record.